127 related articles for article (PubMed ID: 1324678)
1. Mixed-type inhibition of bovine lung angiotensin converting enzyme by lisinopril and its dansyl derivative.
Uçar G; Ozer I
Biochem Pharmacol; 1992 Aug; 44(3):565-70. PubMed ID: 1324678
[TBL] [Abstract][Full Text] [Related]
2. Evidence for the negative cooperativity of the two active sites within bovine somatic angiotensin-converting enzyme.
Binevski PV; Sizova EA; Pozdnev VF; Kost OA
FEBS Lett; 2003 Aug; 550(1-3):84-8. PubMed ID: 12935891
[TBL] [Abstract][Full Text] [Related]
3. Inhibition of rabbit lung angiotensin converting enzyme by idrapril.
Lippi A; Criscuoli M; Sardelli G; Subissi A
Biochem Pharmacol; 1993 Mar; 45(6):1358-62. PubMed ID: 8385462
[TBL] [Abstract][Full Text] [Related]
4. Inhibitor analysis of angiotensin I-converting and kinin-degrading activities of bovine lung and testicular angiotensin-converting enzyme.
Grinshtein SV; Binevski PV; Gomazkov OA; Pozdnev VF; Nikolskaya II; Kost OA
Biochemistry (Mosc); 1999 Aug; 64(8):938-44. PubMed ID: 10498812
[TBL] [Abstract][Full Text] [Related]
5. Inhibition of angiotensin converting enzyme from sheep tissues by captopril, lisinopril and enalapril.
Udupa EG; Rao NM
Indian J Biochem Biophys; 1997 Dec; 34(6):524-8. PubMed ID: 9594434
[TBL] [Abstract][Full Text] [Related]
6. Angiotensin converting enzyme: substrate inhibition.
Schullek JR; Wilson IB
Peptides; 1989; 10(2):431-4. PubMed ID: 2547207
[TBL] [Abstract][Full Text] [Related]
7. Structural constraints of inhibitors for binding at two active sites on somatic angiotensin converting enzyme.
Perich RB; Jackson B; Johnston CI
Eur J Pharmacol; 1994 Feb; 266(3):201-11. PubMed ID: 8174603
[TBL] [Abstract][Full Text] [Related]
8. Characterization of bovine atrial angiotensin-converting enzyme.
Garats EV; Nikolskaya II; Binevski PV; Pozdnev VF; Kost OA
Biochemistry (Mosc); 2001 Apr; 66(4):429-34. PubMed ID: 11403651
[TBL] [Abstract][Full Text] [Related]
9. Enhanced purification protocol for the angiotensin-converting enzyme from bovine systems and investigation of the in vitro effect of some active substances.
Karahan F; Turkoglu V
Chem Biol Interact; 2021 Sep; 347():109604. PubMed ID: 34352275
[TBL] [Abstract][Full Text] [Related]
10. Two binding sites on angiotensin-converting enzyme: evidence from radioligand binding studies.
Perich RB; Jackson B; Rogerson F; Mendelsohn FA; Paxton D; Johnston CI
Mol Pharmacol; 1992 Aug; 42(2):286-93. PubMed ID: 1325031
[TBL] [Abstract][Full Text] [Related]
11. Purification and characterization of angiotensin-converting enzyme (ACE) from sheep lung.
Aydin F; Turkoglu V; Bas Z
Mol Biol Rep; 2021 May; 48(5):4191-4199. PubMed ID: 34086160
[TBL] [Abstract][Full Text] [Related]
12. Exclusion of angiotensin I-converting enzyme as a candidate gene involved in exudative inflammatory resistance in F344/N rats.
Jafarian-Tehrani M; Listwak S; Barrientos RM; Michaud A; Corvol P; Sternberg EM
Mol Med; 2000 Apr; 6(4):319-31. PubMed ID: 10949912
[TBL] [Abstract][Full Text] [Related]
13. Purification of soluble and membrane forms of somatic angiotensin-converting enzyme by cascade affinity chromatography.
Kost OA; Grinshtein SV; Nikolskaya II; Shevchenko AA; Binevski PV
Biochemistry (Mosc); 1997 Mar; 62(3):321-8. PubMed ID: 9275304
[TBL] [Abstract][Full Text] [Related]
14. Characterization of domain-selective inhibitor binding in angiotensin-converting enzyme using a novel derivative of lisinopril.
Watermeyer JM; Kröger WL; O'Neill HG; Sewell BT; Sturrock ED
Biochem J; 2010 Apr; 428(1):67-74. PubMed ID: 20233165
[TBL] [Abstract][Full Text] [Related]
15. Angiotensin-converting enzyme: zinc- and inhibitor-binding stoichiometries of the somatic and testis isozymes.
Ehlers MR; Riordan JF
Biochemistry; 1991 Jul; 30(29):7118-26. PubMed ID: 1649623
[TBL] [Abstract][Full Text] [Related]
16. Angiotensin converting enzyme immobilized on magnetic beads as a tool for ligand fishing.
de Almeida FG; Vanzolini KL; Cass QB
J Pharm Biomed Anal; 2017 Jan; 132():159-164. PubMed ID: 27728854
[TBL] [Abstract][Full Text] [Related]
17. Synthesis and molecular modeling of a lisinopril-tryptophan analogue inhibitor of angiotensin I-converting enzyme.
Nchinda AT; Chibale K; Redelinghuys P; Sturrock ED
Bioorg Med Chem Lett; 2006 Sep; 16(17):4616-9. PubMed ID: 16784843
[TBL] [Abstract][Full Text] [Related]
18. Kinetic probes for inter-domain co-operation in human somatic angiotensin-converting enzyme.
Skirgello OE; Binevski PV; Pozdnev VF; Kost OA
Biochem J; 2005 Nov; 391(Pt 3):641-7. PubMed ID: 16033330
[TBL] [Abstract][Full Text] [Related]
19. A fluorometric assay for angiotensin-converting enzyme activity.
Kapiloff MS; Strittmatter SM; Fricker LD; Snyder SH
Anal Biochem; 1984 Jul; 140(1):293-302. PubMed ID: 6091493
[TBL] [Abstract][Full Text] [Related]
20. Rapid reversal of angiotensin converting enzyme inhibition by lisinopril in the perfused rabbit lung.
Rimar S; Gillis CN
Pulm Pharmacol; 1992 Jun; 5(2):103-9. PubMed ID: 1319250
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
